Facebook Pixel Code

Molbio Diagnostics Share Price

NSE
BSE

MOLBIO DIAGNOSTICS

Smallcap | BSE

Here's the live share price of Molbio Diagnostics along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,297.20
-4.72₹ -64.20
As on Sep 16, 2026, 03:00 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Molbio Diagnostics Price Performance

Today's LowToday's High
₹1,198.60₹1,438.70
₹1,297.20
52 Weeks' Low52 Weeks' High
₹925.80₹1,686.50
₹1,297.20
Open Price
₹1,379.00
Prev. Close
₹1,361.40
Volume
9,09,648

Source: Dion Global

Molbio Diagnostics Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Molbio Diagnostics
2.9324.9624.9624.9624.967.704.55
Apollo Hospitals Enterprise
-2.91-1.883.6916.1010.7919.7012.26
Max Healthcare Institute
-0.792.450.456.01-11.2321.3520.41
Manipal Health Enterprises
-3.77-2.675.365.365.361.721.03
Fortis Healthcare
-4.19-3.99-9.838.04-9.6838.9526.18
Aster DM Quality Care
-5.15-9.72-5.1013.8719.4529.9226.65
Global Health
-5.29-0.8913.4434.653.0526.2427.52
Narayana Hrudayalaya
-2.760.50-1.4111.922.8718.7427.89
Krishna Institute of Medical Sciences
-0.75-5.18-2.4517.550.3823.9624.93
Dr. Lal Pathlabs
-1.340.9815.4341.2815.7417.17-1.49
Dr. Agarwals Health Care
-2.92-0.1813.8418.3113.477.534.45
Vijaya Diagnostic Centre
-3.73-4.3211.0253.8237.0743.9617.50
Rainbow Childrens Medicare
0.47-1.122.5131.090.2612.5826.49
Park Medi World
-0.731.143.5450.9088.8023.7013.61
Metropolis Healthcare
-3.255.539.0626.5712.3115.89-6.14
Healthcare Global Enterprises
-5.05-5.038.0022.830.6623.6423.07
Yatharth Hospital & Trauma Care Services
-1.2915.8718.0650.1724.6236.9423.95
Jupiter Life Line Hospitals
-3.05-12.772.618.17-5.128.575.06
Thyrocare Technologies
-4.67-12.481.5050.1436.0940.484.97
Nephrocare Health Services
-0.714.90-1.9737.9754.3615.579.07

Source: Dion Global

Over the last one year, Molbio Diagnostics has gained 24.96% compared to peers like Apollo Hospitals Enterprise (10.79%), Max Healthcare Institute (-11.23%), Manipal Health Enterprises (5.36%). From a 5 year perspective, Molbio Diagnostics has underperformed peers relative to Apollo Hospitals Enterprise (12.26%) and Max Healthcare Institute (20.41%).

Molbio Diagnostics Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Molbio Diagnostics Stock Technicals

Moving Average

DaySMAEMA
51,235.661,336.18
101,166.111,254.18
201,089.971,162.05
50435.990
100217.990
2001090

Source: Dion Global

Molbio Diagnostics Share Holding Pattern

Molbio Diagnostics Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
18,4410.051.49

Source: Dion Global

* Excluding Index & Arbitrage Funds

Molbio Diagnostics Corporate Actions

Date Time
Announcement
Sep 12, 2026, 03:45 PM IST ISTMolbio Diagnostics - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Sep 09, 2026, 05:47 AM IST ISTMolbio Diagnostics - Change Of Corporate Identification Number (CIN) Of The Company.
Sep 08, 2026, 11:47 PM IST ISTMolbio Diagnostics - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Sep 08, 2026, 08:28 PM IST ISTMolbio Diagnostics - Announcement under Regulation 30 (LODR)-Investor Presentation
Sep 07, 2026, 03:23 PM IST ISTMolbio Diagnostics - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source: Dion Global

About Molbio Diagnostics

Molbio Diagnostics Ltd. is a Public Limited Listed company incorporated on 20/10/2000 and has its registered office in the State of Goa, India. Company's Corporate Identification Number(CIN) is U33125GA2000PLC002909 and registration number is 002909. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 1313.40 Cr. and Equity Capital is Rs. 11.28 Cr. for the Year ended 31/03/2026.

Source: Dion Global

Management

  • Mr. Sriram Natarajan
    Executive Director & CEO
  • Dr. Chandrasekhar Bhaskaran Nair
    Executive Director & Chief Technology Officer
  • Ms. Sangeetha Sriram
    Executive Director
  • Dr. Arun Kumar Jha
    Independent Director
  • Dr. Balram Bhargava
    Independent Director
  • Ms. Nupur Garg
    Independent Director

FAQs on Molbio Diagnostics Share Price

What is the share price of Molbio Diagnostics?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Molbio Diagnostics is ₹1,297.20 as on Sep 16, 2026.

What kind of stock is Molbio Diagnostics?

The Molbio Diagnostics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Molbio Diagnostics?

The market cap of Molbio Diagnostics is ₹14,957.58 Cr as on Sep 16, 2026.

What are today's High and Low prices of Molbio Diagnostics?

Today’s highest and lowest price of Molbio Diagnostics are ₹1,438.70 and ₹1,198.60.

What are the 52 Week High and 52 Week Low of Molbio Diagnostics?

The 52-week high/low is the highest and lowest price at which Molbio Diagnostics stock has traded in the past 52-week or nearly a year. The 52-week high of Molbio Diagnostics is ₹1,686.50 and 52-week low of Molbio Diagnostics is ₹925.80 as on Sep 16, 2026.

How has the Molbio Diagnostics performed historically in terms of returns?

The Molbio Diagnostics has shown returns of -5.56% over the past day, 24.07% for the past month, 24.07% over 3 months, 24.07% over 1 year, 7.56% across 3 years, and 4.47% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Molbio Diagnostics?

P/E ratio of and PB ratio of Molbio Diagnostics are 0.00 and 12.79 on Sep 16, 2026. While the company gives a dividend yield of 0.00 per annum.

Source: Dion Global

Molbio Diagnostics News